This article conducted a systematic literature review and individual patient data (IPD) meta-analysis to compare the efficacy and tolerability of different artemisinin-based or quinine-based treatments for malaria in pregnant women.
As of March 12, 2020, malaria-endemic regions in Africa have reported a few imported COVID-19 cases including in Nigeria, Senegal, and the Democratic Republic of the Congo. Africa needs to be prepared to deal with COVID-19, given the infectious potential of the disease and its capacity to undermine malaria control efforts. There are lessons that can be learned from the 2014-2016 Ebola Outreak which undermined malaria control efforts in Africa. These lessons can be applied to the COVID -19 Outbreak.
In 2019, 8,392,921 malaria cases, including 3,113 deaths have been reported. The population of Burundi is estimated at 11.53 million.
Conventional wisdom has held that mosquitoes have a limited range: However researchers have found in the Sahel, the semidesert region just south of the Sahara Desert, malaria-bearing mosquitoes are borne on winds that allow them to travel hundreds of kilometers.
The conference is organized around three themes: defeating resistance (both to drugs and to insecticides), leveraging data science to better understand disease transmission and innovation in vector control strategies. This program will assess the current threats and gaps in our malaria armamentarium to enable malaria elimination and discuss the emerging innovative approaches for antimalarial drug discovery and development.
Dutch and US researchers have re-engineered non-druggable compounds that block the transmission and metabolism of the malaria parasite Plasmodium falciparum.
Fifty years after a failed attempt to eradicate malaria, the global malaria community is once again seriously considering eradication.
Burundi is currently facing a malaria crisis that has killed nearly the same amount of people as the Ebola outbreak in the Democratic Republic of Congo.
Malaria resistance has been found to have spread rapidly from Cambodia to neighboring countries in Southeast Asia. Using genomic surveillance, researchers detected descendants of one multi-drug resistant malaria strain replacing local parasite populations in multiple countries.
A new study suggests that cutting the duration of a course in therapy to 7 days instead of 14 days and to increasing the dosage in that time period will improve patient participation to full term in anti-relapse therapy for malaria.